NEOVASCULGEN Trademark

Trademark Overview

On Thursday, July 18, 2013, a trademark application was filed for NEOVASCULGEN with the United States Patent and Trademark Office. The USPTO has given the NEOVASCULGEN trademark a serial number of 79135904. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, July 17, 2023. This trademark is owned by Human Stem Cell Institute, JSC. The NEOVASCULGEN trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for treatment of tissue ischemia; biological preparations for medical purposes for therapy for atherosclerotic lower limb ischemia; pharmaceutical preparations for growth induction in blood vessel tissue
neovasculgen

General Information

Serial Number79135904
Word MarkNEOVASCULGEN
Filing DateThursday, July 18, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, July 17, 2023
Registration Number4594913
Registration DateTuesday, September 2, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 17, 2014

Trademark Statements

Description of MarkThe mark consists of Cyrillic characters above the stylized wording "NEOVASCULGEN".
Goods and ServicesMedicines for human purposes for treatment of tissue ischemia; biological preparations for medical purposes for therapy for atherosclerotic lower limb ischemia; pharmaceutical preparations for growth induction in blood vessel tissue
Indication of Colors claimedColor is not claimed as a feature of the mark.
Transliteration StatementThe transliteration of the non-Latin characters in the mark is: "NEOVASCULGEN".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHuman Stem Cell Institute, PJSC
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressRU
Party NameHuman Stem Cell Institute, JSC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRU
Party NameHuman Stem Cell Institute, JSC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRU
Party NameHuman Stem Cell Institute, JSC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRU

Trademark Events

Event DateEvent Description
Monday, February 12, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, February 12, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, May 29, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, April 6, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, April 5, 2022INVALIDATION PROCESSED
Friday, November 19, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 19, 2021CANCELLED SECTION 71
Saturday, October 1, 2016CHANGE OF OWNER RECEIVED FROM IB
Friday, February 27, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 9, 2015FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 9, 2015FINAL DISPOSITION PROCESSED
Tuesday, December 2, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 2, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, June 17, 2014PUBLISHED FOR OPPOSITION
Friday, June 13, 2014NOTIFICATION PROCESSED BY IB
Wednesday, May 28, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 28, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 28, 2014NOTICE OF PUBLICATION
Monday, May 12, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 12, 2014ASSIGNED TO LIE
Wednesday, April 30, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 14, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 14, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 3, 2013REFUSAL PROCESSED BY IB
Tuesday, November 12, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 12, 2013REFUSAL PROCESSED BY MPU
Sunday, November 10, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, November 9, 2013NON-FINAL ACTION WRITTEN
Friday, November 1, 2013ASSIGNED TO EXAMINER
Friday, September 27, 2013APPLICATION FILING RECEIPT MAILED
Monday, September 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 20, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 19, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

neovasculgen preparations tissue ischemia purposes pharmaceutical limb growth induction lower blood